Skip to content
777 Sourcing.

Capability

AI-based drug discovery technology

Suppliers
1
States & provinces
1
Countries
1

1 ai-based drug discovery technology supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

KULEON LLC

SEATTLE, WA

Küleon is a drug discovery and development company leveraging proprietary, AI-based technology to identify novel serotonergic drugs for the targeted treatment of various neuropsychiatric diseases and disorders. It develops small molecule therapeutics for neuropsychiatric conditions modulated through serotonin receptors in the prefrontal cortex of the brain, targeting conditions including addiction, schizophrenia, obesity, pain, inflammation, and neurodegeneration.

small molecule therapeutic development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list AI-based drug discovery technology.

Browse all capabilities